FDA.reportPublic FDA data

FLUOCINOLONE ACETONIDE 0.01% / MINOXIDIL 7% / PROGESTERONE 0.1%

Manufacturer
Sincerus florida, LLC
Effective date
2019-05-08
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:28:38

Label at a glance#

ProductFLUOCINOLONE ACETONIDE 0.01% / MINOXIDIL 7% / PROGESTERONE 0.1%
Active ingredientFLUOCINOLONE ACETONIDE, MINOXIDIL, PROGESTERONE
Label structure4 sections

Label contents#

Full prescribing information#

Directions for use

INSTRUCTIONS FOR USE SECTION

zczc

Sincerus Florida, LLC. Adverse reactions

ADVERSE REACTIONS SECTION

xcxc

Active, inactive

COMPONENTS

sdsd

NDC 72934-4080-8. FLUOCINOLONE ACETONIDE USP 0.01% / MINOXIDIL USP 7% / PROGESTERONE USP 0.1%. Solution 60 gm.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

zxzx

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
FLUOCINOLONE ACETONIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
PROGESTERONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0adb2af5-1ecf-4df5-912b-16ae89228294Product name620240829
b46148e2-ee15-98d5-12f0-f5ec8745f6fcProduct name320220927
76820076-f087-4073-b1d1-aa04b361335eProduct name220220921
65f6255d-41cc-425f-ba54-b1bea4947886Product name520210930
d3229c1a-4e51-4e04-9b13-00d24fd35242Product name120200821
5ba208e4-886f-44da-e218-ab4f4cad2c49Product name520190612
e5a2793f-318b-72fd-b734-c44ecc6f6748Product name220190213
213f0591-95c1-b398-40b7-08b31f66b026Product name420190206
9e453f34-aacb-44d5-a119-c0e3dc1fca2aProduct name120160622
7df2570a-c555-4d82-9189-9247c722b62cProduct name120150402
85490a6b-2306-6bf2-c51b-eb63537dc2daProduct name120140508
85b2d644-53b2-f2dc-4dbc-859116ce56c0Product name120140508
a78a3633-fd06-b0af-63b3-c714de3b3bfaProduct name120140508
b2d0a9c2-fd0c-a9b4-ae41-f6a4eef4fbf6Product name120140508
d048f0e3-3c40-8816-8c5c-0ca5cd189aacProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-4080-82021-01-29C16284748780-1ba0f9c33-1227-a910-e053-dadaa90a0b85FLUOCINOLONE ACETONIDE 0.01% / MINOXIDIL 7% / PROGESTERONE 0.1%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-4080-8FLUOCINOLONE ACETONIDE 0.01% / MINOXIDIL 7% / PROGESTERONE 0.1%60 g in 1 BOTTLE, GLASSSOLUTION601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-4080FLUOCINOLONE ACETONIDE 0.01% / MINOXIDIL 7% / PROGESTERONE 0.1% SOLUTION [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190509_88669481-0372-6b2c-e053-2a95a90a3691.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72934-408072934-4080-8

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
FLUOCINOLONE ACETONIDE0CD5FD6S2MACTIB
MINOXIDIL5965120SH1ACTIB
PROGESTERONE4G7DS2Q64YACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
88669481-0373-6b2c-e053-2a95a90a369188669481-0372-6b2c-e053-2a95a90a36912019-05-08Adverse reactionsExact identifier
spl id: 88669481-0373-6b2c-e053-2a95a90a3691
spl set id: 88669481-0372-6b2c-e053-2a95a90a3691

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.